| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, Division of Endocrinology and Metabolism, and Department of Pathology, University of Florida Gainesville, Florida 32610
Address requests for reprints to: Thomas J. Merimee, M.D., Department of Medicine, Division of Endocrinology and Metabolism, University of Florida, Box J-226, JHMHC, Gainesville, Florida 32610–0226.
Preliminary data suggested different patterns of hormonal control of linear growth in males and females. To better define these patterns, serum samples were collected from 75–125 boys and a similar number from girls for each year of age between 3–16 yr (n = 2416). Fewer samples were collected from 2-yr-olds, newborns, and adults (n = 151). Samples for each age were aliquoted, combined, and assayed for GH, GHbinding protein (GHBP), insulin-like growth factor-I, and testosterone.
GHBP, expressed as a percentage of the [125I[GH bound, increased yearly in males and females, with no relationship to the secretion of sex hormones. The increase in binding of [125I[ GH and, by inference, GH receptors occurred at a greater rate between the ages of 2–10 yr than between 10–16 yr (in terms of absolute binding, 1.2 ± 0.11% vs. 0.38 ± 0.04% yearly; P < 0.001). In each age group, however, the increase in GHBP exhibited a strong positive correlation with linear height (r = 0.96–0.98 in males; r = 0.92–0.99 in females).
Before puberty, GH and insulin-like growth factor-I concentrations were consistently greater in females. Between 10–16 yr of age, height velocity (centimeters of growth per yr) correlated strongly with GH in girls (r = 0.86), but did not correlate with GH in boys of a similar age (r = –0.13). The major pubertal growth spurt in males strongly correlated with a rise in serum testosterone concentration beginning at age 11 yr (r = 0.92). Small peaks of GH secretion before and after the major period of accelerated growth in males possibly prolonged the major growth phase, but did not initiate it.
* This work was supported in part by a grant (AM-18130) from the NIAMDD, NIH; grants from the General Clinical Research Center Program of the Division of Research Resources; and NIH (RR-00082). Also supported by a contract with the Department of Health and Rehabilitative Services of the State of Florida for the University of Florida Diabetes Research Education and Treatment Center.
Received February 19, 1991.
This article has been cited by other articles:
![]() |
R. Garzon, S. F. Soriano, J. M. Rodriguez-Frade, L. Gomez, A. Martin de Ana, M. Sanchez-Gomez, C. Martinez-A, and M. Mellado CXCR4-mediated Suppressor of Cytokine Signaling Up-regulation Inactivates Growth Hormone Function J. Biol. Chem., October 22, 2004; 279(43): 44460 - 44466. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Herrinton and G. Husson Relation of Childhood Height and Later Risk of Breast Cancer Am. J. Epidemiol., October 1, 2001; 154(7): 618 - 623. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |